The global postpartum hemorrhage (PPH) treatment devices market is marked by the presence of several players. The vendor landscape of the market is thus fragmented. According to Transparency Market Research (TMR), key players in the market are currently spending in promotional events to counter conventional PPH treatment methods. This, however, increases operational cost of manufacturing PPH devices, whereas it is imperative for players to keep their product prices low for penetrating into emerging markets.
Browse the Details of this Report at: http://www.transparencymarketresearch.com/postpartum-hemorrhage-treatment-devices-market.html
Escalating Cases of Pregnancy Related Complications Make Affordable PPH Treatment Devices Indispensable
The high prevalence of PPH is expected to fuel demand for advanced PPH treatment devices worldwide. In the last few years death in women due to pregnancy related complications has surged significantly. According to the United States Agency for International Development (USAID) and the World Bank, over 99% of maternal deaths occur in developing nations where affordable healthcare and services of skilled professionals are not easily available in remote locations.
“Companies manufacturing PPH treatment devices are creating marketing strategies to capitalize on the untapped opportunities in developing countries,” said a lead TMR analyst. This is expected to be a key driver of demand for PPH treatment devices. “The market will also gain from planned government initiatives and training aimed at ensuring remote areas access to affordable and quality healthcare services,” he added. Besides these, escalating risk factors associated with pregnancy and PPH will impel organizations to focus on production of effective devices for PPH treatment.
Lack of Awareness Inhibits PPH Treatment Device Manufacturers Entry in Developing Economies
PPH treatment devices are found in the market since the past two decades. However, a large section of people residing in developing and less developed countries lack awareness about the availability of such solutions. This is a key factor dampening the market’s growth in countries across Asia Pacific, the Middle East, and sub-Saharan Africa to an extent.
The market is also witnessing low level of acceptance for novel of unconventional PPH treatment devices. Furthermore, lack of skilled professionals also inhibits the widespread adoption of advanced PPH treatment devices across developing nations.
Nevertheless, companies are focusing on developing their existing distribution channels to spread their business across developing and less developed countries. Additionally, they are making efforts to promote awareness about the availability of these solutions. This is expected to created growth opportunities for the market in the forthcoming years.
Regionally, North America dominated the market in 2014, accounting for over 36.1% of the market based on value. Increased access to healthcare and the availability of advanced medical devices are the key factors driving the PPH treatment devices market in North America.
Perceive the Sample PDF of this report at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6164
By products the market was led by the uterine balloon tamponade segment in 2014. Due to commercial availability, high effectiveness, and ease of use the products offer, the uterine balloon tamponade segment is expected to rise at 4.9% CAGR between 2015 and 2023.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453